Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for primary dyslipidemia
ChiCTR1900021361Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of berberine in primary dyslipidaemia (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Low-density lipoprotein cholesterol at week 12. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
berberine
03
Conditions
primary dyslipidaemia
Beyond the preview
Go deeper on ChiCTR1900021361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021361.